UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment

Annual review of pathology, 2009-01, Vol.4 (1), p.49-70

2009

Link zum Volltext

Verfügbarkeit prüfen

Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2013-03, Vol.73 (6), p.1733-1741

2013

Link zum Volltext

Verfügbarkeit prüfen

PET/CT in the management of thyroid cancers

American journal of roentgenology (1976), 2014-06, Vol.202 (6), p.1316

2014

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma

Endocrine pathology, 2018-03, Vol.29 (1), p.59-67

2018

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of head and neck squamous cell cancer among HIV-infected patients

Journal of acquired immune deficiency syndromes (1999), 2014-04, Vol.65 (5), p.603

2014

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Cancer Radiotherapy through Immunosuppressive Stromal Cell Destruction in Tumors

Clinical cancer research, 2014-02, Vol.20 (3), p.644-657

2014

Link zum Volltext

Verfügbarkeit prüfen

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer

Genome medicine, 2018-07, Vol.10 (1), p.54-18, Article 54

2018

Link zum Volltext

Verfügbarkeit prüfen

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

Cancer Immunology, Immunotherapy, 2013-01, Vol.62 (1), p.171-182

2013

Link zum Volltext

Verfügbarkeit prüfen

The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma

Surgery, 2013-12, Vol.154 (6), p.1272-1282

2013

Link zum Volltext

Verfügbarkeit prüfen

Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006773

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

Journal for immunotherapy of cancer, 2019-04, Vol.7 (1), p.96-96, Article 96

2019

Link zum Volltext

Verfügbarkeit prüfen

In-situ tumor vaccination: Bringing the fight to the tumor

Human vaccines & immunotherapeutics, 2015-08, Vol.11 (8), p.1901-1909

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas

The Laryngoscope, 2009-08, Vol.119 (8), p.1542-1549

2009

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic challenges and successful organ‐preserving therapy in a case of secretory carcinoma of minor salivary glands

Cancer reports, 2022-03, Vol.5 (3), p.e1491-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas

Oral oncology, 2013-03, Vol.49 (3), p.244-248

2013

Link zum Volltext

Verfügbarkeit prüfen

Activation of Akt as a Mechanism for Tumor Immune Evasion

Molecular therapy, 2009-03, Vol.17 (3), p.439-447

2009

Link zum Volltext

Verfügbarkeit prüfen

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Journal of translational medicine, 2019-12, Vol.17 (1), p.429-429, Article 429

2019

Link zum Volltext

Verfügbarkeit prüfen

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer

PloS one, 2015-01, Vol.10 (1), p.e116389-e116389

2015

Link zum Volltext

Verfügbarkeit prüfen

Biology of Human Papillomavirus Infection and Immune Therapy for HPV-Related Head and Neck Cancers

Otolaryngologic clinics of North America, 2012-08, Vol.45 (4), p.807-822

2012

Link zum Volltext

Verfügbarkeit prüfen

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Immunity (Cambridge, Mass.), 2018-12, Vol.49 (6), p.1148-1161.e7

2018

Link zum Volltext

Verfügbarkeit prüfen

Xenograft Model for Therapeutic Drug Testing in Recurrent Respiratory Papillomatosis

Annals of otology, rhinology & laryngology, 2015-02, Vol.124 (2), p.110-115

2015

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay

Oral oncology, 2014-06, Vol.50 (6), p.600-604

2014

Link zum Volltext

Verfügbarkeit prüfen

The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier

Cancer treatment and research, 2020, Vol.180, p.173-195

2020

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal Cancer

The cancer journal (Sudbury, Mass.), 2022-09, Vol.28 (5), p.407

2022

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus-related carcinomas of the sinonasal tract

The American journal of surgical pathology, 2013-02, Vol.37 (2), p.185-192

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Englisch
(241)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment

Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma

PET/CT in the management of thyroid cancers

PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma

Epidemiology of head and neck squamous cell cancer among HIV-infected patients

Enhanced Cancer Radiotherapy through Immunosuppressive Stromal Cell Destruction in Tumors

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma

Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

In-situ tumor vaccination: Bringing the fight to the tumor

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas

Diagnostic challenges and successful organ‐preserving therapy in a case of secretory carcinoma of minor salivary glands

Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas

Activation of Akt as a Mechanism for Tumor Immune Evasion

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer

Biology of Human Papillomavirus Infection and Immune Therapy for HPV-Related Head and Neck Cancers

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Xenograft Model for Therapeutic Drug Testing in Recurrent Respiratory Papillomatosis

Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay

The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier

Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal Cancer

Human papillomavirus-related carcinomas of the sinonasal tract

Suchergebnisse filtern